Tenofovir Disoproxil Fumarate-Associated Nephrotoxicity
in HIV-Infected Patients: A Prospective Controlled Study
Khobchok Woratanarat MD*,
Talerngsak Kanjanabuch MD**, Chusana Suankratay MD, PhD*
Affiliation :
* Division of Infectious Diseases, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
** Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
Objective : To evaluate all renal functions in patients receiving TDF and other nucleoside analogues.
Material and Method: A prospective controlled study evaluating glomerular and tubular functions was conducted in patients
receiving either TDF- or AZT-containing antiretroviral therapy regimen between 2008 and 2009 at King Chulalongkorn
Memorial Hospital, Bangkok, Thailand.
Results : Of 51 patients, there were 39 and 12 patients, with the mean age of 40.037.7 and 37.27.6 years in the TDF and
AZT groups. There was no difference between the two groups, except longer HIV infection duration, higher patient number
with previous antiretroviral therapy and undetectable HIV RNA, and higher CD4 count in the TDF group. All and most
patients had received lamivudine and a non-nucleoside analogue. The mean change of eGFR from the baseline to the six
months of follow-up was +1.32 and +5.88 mL/minute in the TDF and AZT groups. Proximal tubular dysfunction was not
noted at three and six months of follow-up. However, patients in the TDF group had lower serum phosphate and higher
renal potassium loss than the AZT group at six months of follow-up (p = 0.08 and p = 0.09, respectively). No patients in
the two groups with distal tubular dysfunctions were noted.
Conclusion : To our knowledge, this is the first prospective controlled study extensively evaluating all renal functions in
patients receiving TDF and AZT. There are no differences in the eGFR decline between the two groups during the six months
of follow-up. However, a trend towards greater renal loss of potassium and phosphate is noted in the TDF group. A study
with longer duration of follow-up is needed.
Keywords : Tenofovir disoproxil fumarate, Nephrotoxicity, HIV, AIDS, Fanconi syndrome, Thailand
All Articles
Download